SURMOUNT-3

Definition

Tirzepatide started after a 12-week intensive lifestyle lead-in (Wadden et al., Nature Medicine 2023): a further −18.4% against −2.5% on placebo across the 72-week treatment phase. The useful reading is that the drug and the lifestyle work are additive, not alternatives — which is worth remembering when a seller bundles coaching and charges for it.

SURMOUNT-3 trial deep-dive →

GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature. Not one of them is an AI-generated summary.

Other terms under trial

• SURMOUNT-5
• SURMOUNT-2
• SURPASS-2
• SUSTAIN-6
• REWIND
• PIONEER 6
• STEP-HFpEF
• EXSCEL
• ELIXA
• AMPLITUDE-O
• HARMONY OUTCOMES
• SCALE Diabetes
• STEP 2
• SUMMIT
• SCALE Maintenance

Where the evidence lives

• SURMOUNT-3 trial deep-dive
• The full GLP-1 glossary (149 terms, 8 categories)
• Research articles — written from primary sources
• Tools and calculators
• Compare GLP-1 telehealth providers